(NCMI) National CineMedia - Ratings and Ratios
Cinema Advertising, Lobby Screens, Digital Ads, Trivia App
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 43.2% |
| Value at Risk 5%th | 64.4% |
| Relative Tail Risk | -9.35% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.93 |
| Alpha | -49.57 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.411 |
| Beta | 0.729 |
| Beta Downside | 0.753 |
| Drawdowns 3y | |
|---|---|
| Max DD | 77.75% |
| Mean DD | 23.10% |
| Median DD | 20.88% |
Description: NCMI National CineMedia October 24, 2025
National CineMedia, Inc. (NASDAQ: NCMI) operates the largest cinema-advertising network in North America through its subsidiary, National CineMedia LLC. The firm sells ad inventory across three core platforms: the pre-show “Noovie” entertainment block, the Lobby Entertainment Network (LED screens in theater lobbies), and a suite of digital products such as NCM Boost, Boomerang, and the Noovie Trivia app. Its revenue model relies on long-term affiliate agreements with theater owners, allowing NCMI to monetize both traditional screen time and emerging digital formats.
Key performance indicators from the most recent fiscal year (2023) show total revenue of roughly **$222 million**, with digital-only inventory contributing about **12%** of that total-a growth rate of **~30% YoY**, reflecting the broader industry shift toward programmatic and addressable advertising. The company’s EBITDA margin hovered near **15%**, indicating relatively high operating leverage once fixed costs of network infrastructure are covered. Primary economic drivers include (1) post-COVID rebound in cinema attendance (U.S. box-office admissions were up ~18% YoY in 2023), (2) discretionary consumer spending trends, and (3) the overall health of the advertising market, which is sensitive to corporate marketing budgets and CPI-adjusted media costs.
If you want a deeper, data-driven assessment of NCMI’s valuation and risk profile, a quick look at ValueRay’s analyst toolkit can provide the granular metrics and scenario analysis you need.
NCMI Stock Overview
| Market Cap in USD | 384m |
| Sub-Industry | Advertising |
| IPO / Inception | 2007-02-08 |
| Return 12m vs S&P 500 | -45.2% |
| Analyst Rating | 4.25 of 5 |
NCMI Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 3.00% |
| Yield on Cost 5y | 0.38% |
| Yield CAGR 5y | -47.56% |
| Payout Consistency | 71.0% |
| Payout Ratio | - |
NCMI Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | -3.66% |
| CAGR/Max DD Calmar Ratio | -0.05 |
| CAGR/Mean DD Pain Ratio | -0.16 |
| Current Volume | 416.4k |
| Average Volume | 405.5k |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (-15.1m TTM) > 0 and > 6% of Revenue (6% = 14.2m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA -1.86pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 19.12% (prev 30.36%; Δ -11.24pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 32.1m > Net Income -15.1m (YES >=105%, WARN >=100%) |
| Net Debt (-18.9m) to EBITDA (25.2m) ratio: -0.75 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.90 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (94.3m) change vs 12m ago -0.96% (target <= -2.0% for YES) |
| Gross Margin 42.22% (prev 32.56%; Δ 9.66pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 48.34% (prev 46.65%; Δ 1.70pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -17.62 (EBITDA TTM 25.2m / Interest Expense TTM 800.0k) >= 6 (WARN >= 3) |
Altman Z'' 4.24
| (A) 0.10 = (Total Current Assets 95.7m - Total Current Liabilities 50.5m) / Total Assets 451.9m |
| (B) 0.47 = Retained Earnings (Balance) 213.5m / Total Assets 451.9m |
| (C) -0.03 = EBIT TTM -14.1m / Avg Total Assets 489.0m |
| (D) 2.13 = Book Value of Equity 216.0m / Total Liabilities 101.4m |
| Total Rating: 4.24 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 52.74
| 1. Piotroski 6.0pt |
| 2. FCF Yield 7.21% |
| 3. FCF Margin 11.13% |
| 4. Debt/Equity 0.03 |
| 5. Debt/Ebitda -0.75 |
| 6. ROIC - WACC (= -12.26)% |
| 7. RoE -4.07% |
| 8. Rev. Trend 24.85% |
| 9. EPS Trend 33.42% |
What is the price of NCMI shares?
Over the past week, the price has changed by -2.20%, over one month by -6.69%, over three months by -4.48% and over the past year by -38.66%.
Is NCMI a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the NCMI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 6.3 | 56.3% |
| Analysts Target Price | 6.3 | 56.3% |
| ValueRay Target Price | 3.7 | -7.5% |
NCMI Fundamental Data Overview November 18, 2025
P/E Forward = 133.3333
P/S = 1.6241
P/B = 1.0681
P/EG = -3.82
Beta = 1.377
Revenue TTM = 236.4m USD
EBIT TTM = -14.1m USD
EBITDA TTM = 25.2m USD
Long Term Debt = 10.0m USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.70m USD (from shortTermDebt, last fiscal year)
Debt = 11.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -18.9m USD (from netDebt column, last quarter)
Enterprise Value = 364.9m USD (383.8m + Debt 11.0m - CCE 29.9m)
Interest Coverage Ratio = -17.62 (Ebit TTM -14.1m / Interest Expense TTM 800.0k)
FCF Yield = 7.21% (FCF TTM 26.3m / Enterprise Value 364.9m)
FCF Margin = 11.13% (FCF TTM 26.3m / Revenue TTM 236.4m)
Net Margin = -6.39% (Net Income TTM -15.1m / Revenue TTM 236.4m)
Gross Margin = 42.22% ((Revenue TTM 236.4m - Cost of Revenue TTM 136.6m) / Revenue TTM)
Gross Margin QoQ = 44.01% (prev 16.22%)
Tobins Q-Ratio = 0.81 (Enterprise Value 364.9m / Total Assets 451.9m)
Interest Expense / Debt = 0.91% (Interest Expense 100.0k / Debt 11.0m)
Taxrate = 0.0% (0.0 / 1.60m)
NOPAT = -14.1m (EBIT -14.1m * (1 - 0.00%)) [loss with tax shield]
Current Ratio = 1.90 (Total Current Assets 95.7m / Total Current Liabilities 50.5m)
Debt / Equity = 0.03 (Debt 11.0m / totalStockholderEquity, last quarter 350.5m)
Debt / EBITDA = -0.75 (Net Debt -18.9m / EBITDA 25.2m)
Debt / FCF = -0.72 (Net Debt -18.9m / FCF TTM 26.3m)
Total Stockholder Equity = 370.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.34% (Net Income -15.1m / Total Assets 451.9m)
RoE = -4.07% (Net Income TTM -15.1m / Total Stockholder Equity 370.6m)
RoCE = -3.70% (EBIT -14.1m / Capital Employed (Equity 370.6m + L.T.Debt 10.0m))
RoIC = -3.78% (negative operating profit) (NOPAT -14.1m / Invested Capital 373.1m)
WACC = 8.48% (E(383.8m)/V(394.8m) * Re(8.70%) + D(11.0m)/V(394.8m) * Rd(0.91%) * (1-Tc(0.0)))
Discount Rate = 8.70% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.35%
[DCF Debug] Terminal Value 67.54% ; FCFE base≈31.9m ; Y1≈21.0m ; Y5≈9.59m
Fair Price DCF = 1.80 (DCF Value 169.1m / Shares Outstanding 93.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 33.42 | EPS CAGR: -18.66% | SUE: 0.20 | # QB: 0
Revenue Correlation: 24.85 | Revenue CAGR: -12.56% | SUE: -0.01 | # QB: 0
Additional Sources for NCMI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle